85 related articles for article (PubMed ID: 1861541)
21. Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells.
Lotz M; Ranheim E; Kipps TJ
J Exp Med; 1994 Mar; 179(3):999-1004. PubMed ID: 8113691
[TBL] [Abstract][Full Text] [Related]
22. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
[TBL] [Abstract][Full Text] [Related]
23. Flow cytochemical analysis of peripheral lymphocytes in chronic B-lymphocytic leukemia. Prognostic role of the blast count determined by the H*1 system and its correlation with morphologic features.
Lanza F; Moretti S; Latorraca A; Scapoli G; Rigolin F; Castoldi G
Leuk Res; 1992; 16(6-7):639-46. PubMed ID: 1635382
[TBL] [Abstract][Full Text] [Related]
24. Essential in vitro test before treatment of patients with intractable chronic lymphocytic leukemia.
Schrek R
Acta Haematol; 1990; 84(2):104-5. PubMed ID: 2120881
[TBL] [Abstract][Full Text] [Related]
25. Pathogenesis of intractable chronic lymphocytic leukemia (ICLL).
Schrek R
Med Hypotheses; 1989 Dec; 30(4):229-30. PubMed ID: 2615683
[TBL] [Abstract][Full Text] [Related]
26. Kinetics of excision repair of UV-induced DNA damage, measured using the comet assay.
Myllyperkiö MH; Koski TR; Vilpo LM; Vilpo JA
Mutat Res; 2000 Mar; 448(1):1-9. PubMed ID: 10751617
[TBL] [Abstract][Full Text] [Related]
27. Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.
Molica S; Giannarelli D; Levato L; Gentile M; Mirabelli R; Morabito F
Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e55-60. PubMed ID: 25445470
[TBL] [Abstract][Full Text] [Related]
28. Multicentric investigation of ionising radiation-induced cell death as a predictive parameter of individual radiosensitivity.
Greve B; Dreffke K; Rickinger A; Könemann S; Fritz E; Eckardt-Schupp F; Amler S; Sauerland C; Braselmann H; Sauter W; Illig T; Schmezer P; Gomolka M; Willich N; Bölling T
Apoptosis; 2009 Feb; 14(2):226-35. PubMed ID: 19142732
[TBL] [Abstract][Full Text] [Related]
29. A study of splenic irradiation in chronic lymphocytic leukemia.
Guiney MJ; Liew KH; Quong GG; Cooper IA
Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):225-9. PubMed ID: 2912945
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of low-malignancy lymphomas by spleen irradiation].
Słomkowski M; Jeleniewska A; Apel D; Sablińska K; Maj S
Acta Haematol Pol; 1990; 21(1):85-91. PubMed ID: 2260412
[TBL] [Abstract][Full Text] [Related]
31. Effect of subsequent acute-dose irradiation on cell survival in vitro following low dose-rate exposures.
Mitchell CR; Joiner MC
Int J Radiat Biol; 2002 Nov; 78(11):981-90. PubMed ID: 12456285
[TBL] [Abstract][Full Text] [Related]
32. Splenic irradiation in chronic lymphocytic leukemia.
Chisesi T; Capnist G; Dal Fior S
Eur J Haematol; 1991 Apr; 46(4):202-4. PubMed ID: 2015875
[TBL] [Abstract][Full Text] [Related]
33. Intrinsic susceptibility to radiation-induced apoptosis of human lymphocyte subpopulations.
Schmitz A; Bayer J; Déchamps N; Thomas G
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):769-78. PubMed ID: 14529783
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic value of absolute monocyte count in chronic lymphocytic leukaemia].
Szerafin L; Jakó J; Riskó F
Orv Hetil; 2015 Apr; 156(15):592-7. PubMed ID: 25845318
[TBL] [Abstract][Full Text] [Related]
35. Effects of hyperthermia on radiosensitivity of normal and leukaemic lymphocytes.
Schrek R; Stefani SS
Br J Exp Pathol; 1980 Jun; 61(3):256-60. PubMed ID: 7426381
[TBL] [Abstract][Full Text] [Related]
36. Differences between responsive and intractable chronic lymphocytic leukemia.
Schrek R
Med Hypotheses; 1990 Feb; 31(2):81-2. PubMed ID: 2325590
[TBL] [Abstract][Full Text] [Related]
37. Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia.
Eisterer W; Bechter O; Söderberg O; Nilsson K; Terol M; Greil R; Thaler J; Herold M; Finke L; Günthert U; Montserrat E; Stauder R
Leuk Res; 2004 Oct; 28(10):1043-51. PubMed ID: 15289016
[TBL] [Abstract][Full Text] [Related]
38. Prognostic features and survival in young adults with early/intermediate chronic lymphocytic leukemia (B-CLL): a single institution study.
Dhodapkar M; Tefferi A; Su J; Phyliky RL
Leukemia; 1993 Aug; 7(8):1232-5. PubMed ID: 8350623
[TBL] [Abstract][Full Text] [Related]
39. Peripheral blood lymphocyte phenotype of ZAP-70⁺ and ZAP-70⁻ patients with B-cell chronic lymphocytic leukaemia.
Rivkina A; Holodnuka-Kholodyuk I; Murovska M; Soloveichika M; Lejniece S
Exp Oncol; 2015 Mar; 37(1):73-6. PubMed ID: 25804237
[TBL] [Abstract][Full Text] [Related]
40. Relationship between lymphocyte size and enzyme activities in two morphological variants of B-chronic lymphocytic leukaemia.
Vives Corrons JL; Colomer D; Pujades A; Matutes E; Pastor C; Aymerich M
Acta Haematol; 1989; 82(1):22-6. PubMed ID: 2528263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
